In this Health Professional Radio interview – Learn how Triumvira Immunologics is developing novel T-Cell therapies to treat cancer patients. Discover how their autologous and allogeneic targeted therapeutics co-opt the natural biology of T cells.
Find out more from CEO Dr. Paul Lammers.
